Design [Regulatives / Guidelines]

posted by Pharma_88 – India, 2020-08-27 14:07 (63 d 04:49 ago) – Posting: # 21893
Views: 1,576

Dear All,

We are thinking to perform steady state BE study for XXX submission where Test product is ER formulation and Reference product is IR formulation. Further, Its HVD product. So, question is whether is this feasible to conduct replicate BE IR vs ER and if yes then what are the parameters for conclusion?


Complete thread:

 Admin contact
21,179 posts in 4,414 threads, 1,477 registered users;
online 7 (0 registered, 7 guests [including 6 identified bots]).
Forum time: Thursday 18:56 UTC (Europe/Vienna)

With four parameters I can fit an elephant,
and with five I can make him wiggle his trunk.    John von Neumann

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz